Dolby Laboratories

DLB Industrials Specialty Business Services

Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024. In the quarter to June 2026, revenue fell 3.34%, EPS fell 37.5% and free cash flow grew 157.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.

59.95 0.88 −1.45%
Market cap
$5.7B
P/E
25.2×
Fwd P/E
16.5×
Dividend yield
2.40%
F-score
6/9
Altman Z
9.17
Beneish M
−2.80
Dividend safety
85/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

27.21 25.59 23.46 22.09
P/S ratio
5.14 4.58 4.19 3.66
P/FCF ratio
16.13 15.87 21.60 13.72
P/Operating CF
56.48 111.88 61.82 29.59
P/B ratio
2.64 2.36 2.18 1.91
EV/Sales
4.55 4.04 3.70 3.11
EV/EBITDA
16.90 15.55 14.21 12.31
EV/FCF
14.28 13.99 19.06 11.67
Current Ratio
3.17 3.17 2.98 3.19
Net Debt/EBITDA
(14.64) (8.19) (4.82) (12.45)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
3.68% 3.91% 4.26% 4.53%
Free Cash Flow Yield
6.20% 6.30% 4.63% 7.29%
Free Cash Flow per Share
1.05 0.59 0.49 1.67
Book value per Share
27.45 27.26 27.59 27.51
Free Cash Flow
100.99 56.04 46.42 157.67
EV/EBIT
23.19 21.85 19.98 17.63
Other line items

Show all line items

Columns are period end dates